The European Union’s Court of Justice (ECJ) has rendered its two long-awaited judgments in the European Commission’s (EC’s) perindopril case. The 27 June 2024 judgments concern:
- The EC’s appeal of the General Court’s...more
7/29/2024
/ Antitrust Provisions ,
EU ,
European Commission ,
European Court of Justice (ECJ) ,
License Agreements ,
Licensees ,
Life Sciences ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
Treaty on the Functioning of the European Union (TFEU)